DCGI

Jubilant Pharma develops Remdesivir oral formulation

Jubilant Pharma Limited has recently announced that it has successfully completed safety and pharmacokinetic/absorption studies in animals and healthy human…

4 years ago

Union Health Ministry Issues Regulatory Pathways for foreign produced COVID-19 Vaccines

The Union Government has today issued the Regulatory Pathway in India for COVID-19 vaccines approved for restricted use by US…

4 years ago

Keep checks to avoid black marketing, overcharging of Remdesivir: DCGI to States, UTs

A notice has been released by the Drugs Controller General of India ordering all the States and UTs to perform…

4 years ago

Zydus Cadila seeks approval from DCGI for the use of Hepatitis C to treat COVID-19 patients

Zydus Cadila, has announced that it was seeking approval from Drug controller General of India (DCGI) for the use of…

4 years ago

DCGI permits clinical trial for third dose of Covaxin

The Drugs Controller General of India (DCGI) has permitted Bharat Biotech to give a third dose of Covaxin to a…

4 years ago

Sputnik V gets no Nod from CDSCO panel

An expert panel of India’s central drug authority has sought additional data and information from Dr Reddy’s Laboratories which has…

4 years ago

COVID-19 vaccine Sputnik V phase – 3 trials results to come in April – SOURCES

The Dr Reddy's completes Sputnik V phase - 3 trials of COVID-19 vaccine result of trials is expected to come…

4 years ago